Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
NCITE secures its first-ever patent for a chatbot, revolutionizing threat reporting with a user-friendly, conversational approach.
BMW's E Ink tech offers customizable car colors, set to revolutionize vehicle aesthetics by 2027 with energy-efficient designs.
Tula's DMD improves EV efficiency by 0.6% in China. Further gains expected, aiding the EV transition.
Venmo and PayPal now support crypto transfers via ENS names, simplifying transactions for 270 million US users.
ENS names simplify crypto transfers for Venmo, PayPal's 270M users, boosting blockchain adoption.
California invites AI developers to address homelessness and housing shortages using innovative technology solutions this month.
Sony patent hints at new VR headset with prescription lenses, aiming to enhance user comfort and reduce bulk.
Sandbox VR announces 60% franchise growth. Plans for 280 new locations, enhancing global presence and immersive experiences.
Over 80% of AI projects fail due to goal misalignment, tech distractions, and data issues, wasting billions. Learn why.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.